The COVID-19 pandemic caused a staggering 16.8 million person-years of life lost across 18 European countries, with nearly 60% of those years expected to be lived without disability. The research highlights both direct COVID-19 deaths and indirect impacts like healthcare disruptions and rising non-COVID mortality.
FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals
This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on innovation in cell and gene therapies. Against
January 20, 2025